USP39 and breast cancer: Interestingly, USP39 is also subject to FOXM1 regulation Therefore, it was indicated that USP39 and FOXM1 constitute a negative feedback loop that co-regulates the proliferation of BC cells, thereby offering a novel approach to targeting the USP39-FOXM1 axis for the treatment of BC.